pembrolizumab
merck
['key,note,716', 'melanoma', 'keynote-716']
in presenting the results of phase 3 keynote-716 melanoma study said i think every patient should be offered this treatment as an option. #asco23 
NCI-designated Comprehensive Cancer Center and a global leader in cancer research and cancer care affiliated with @PittTweet